MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

By Groenendijk Floris   Taal Walter   Dubbink Hendrikus   Haarloo Cathleen   Kouwenhoven Mathilde   Bent Martin   Kros Johan   Dinjens Winand  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 405-417

Springer Publishing Company

Access to resources Recommend Favorite

Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme

By Martinez Ramon   Schackert Gabriele   Esteller Manel  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

O ⁶-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma

By Sonoda Yukihiko   Yokosawa Michiko   Saito Ryuta   Kanamori Masayuki   Yamashita Yoji   Kumabe Toshihiro   Watanabe Mika   Tominaga Teiji  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 352-358

Springer Publishing Company

Access to resources Recommend Favorite

Chromosomal aberrations and hprt mutant frequencies in long-term American thorotrast survivors

By Platz E. A.   Wiencke J. K.   Kelsey K. T.   Janower M. L.   Schottenfeld D.   Travis L. B.   Goldman M. B.  

International Journal of Radiation Biology, Vol. 76, Iss. 7, 2000-07 ,pp. : 955-961

Informa Healthcare

Access to resources Recommend Favorite

DNA-repair gene variants are associated with glioblastoma survival

By Wibom Carl   Sjöström Sara   Henriksson Roger   Brännström Thomas   Broholm Helle   Rydén Patrik   Johansen Christoffer   Collatz-Laier Helle   Hepworth Sara   McKinney Patricia A.   Bethke Lara   Houlston Richard S.   Andersson Ulrika   Melin Beatrice S.  

Acta Oncologica, Vol. 51, Iss. 3, 2012-03 ,pp. : 325-332

Informa Healthcare

Access to resources Recommend Favorite